The U.S. Food and Drug Administration approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies.
Montelukast is in a class of medications called leukotriene receptor antagonists. It works by blocking the action of leukotrienes, substances in the body that cause the symptoms of asthma and hayfever (allergic rhinitis).
?For people who suffer from chronic health conditions such as asthma and allergies, it is important to have effective and affordable treatment options,? said Gregory P. Geba, M.D., M.P.H., director of the Office of Generic Drugs in FDA?s Center for Drug Evaluation and Research. ?The generic products approved today will expand those options for patients.?
Montelukast should not be used for relief of a sudden asthma attack. Some side effects of montelukast can be serious. A health care provider should be immediately contacted if any of the following symptoms are experienced: behavior and mood-related changes such as aggression, depression, or hallucinations; feeling of ?pins and needles? or numbness in the arms or legs; rash; flu-like symptoms; or severe pain and swelling of the sinuses.
In clinical trials, the most common side effects reported by patients using Singulair included: upper respiratory infection, fever, headache, sore throat, cough, stomach pain, diarrhea, ear ache, flu, runny nose, and sinus infection.
Apotex Inc., Aurobindo Pharma, Endo Pharmaceuticals, Glenmark Generics, Kudco Ireland Inc., Mylan Inc., Roxane Laboratories, Sandoz Inc., Teva Pharmaceuticals Inc., and Torrent Pharmaceuticals have gained FDA approval for generic montelukast tablets. Apotex, Aurobindo, Endo, Kudco, Mylan, Roxane, Sandoz, Teva, and Torrent have received approval for chewable tablets. Teva has received approval for the oral granule form.
Information about the availability of generic montelukast sodium can be obtained from the manufacturers.
Generic drugs approved by FDA are of the same high quality and strength as brand-name drugs. The generic manufacturing and packaging sites must pass the same quality standards as those for brand-name drugs.
Source: U.S. Food and Drug Administration, USA
- « Chloroflouorocarbons OTC asthma inhalers will no longer be made or sold in US
- Asthma children are more likely to be bullied »
Editor Health NewsAsthma and allergies drug Singulair as generic version approved
by Editor Health News ( Author at Health Newstrack )
Posted on August 9th, 2012 at 9:45 am.
Track Health News on: Asthma